International Journal of Endocrinology / 2017 / Article / Tab 1

Review Article

Does HbA1c Level Have Clinical Implications in Diabetic Patients Undergoing Coronary Artery Bypass Grafting? A Systematic Review and Meta-Analysis

Table 1

Characteristics of the studies included in the meta-analysis.

Study IDYearCountryStudy designSample sizeMale (%)Follow-up durationFollow-up rate (%)HbA1c levelsStudy outcomesNOS score

Sato et al. [21]2010CanadaProspective cohort13070.830 days100%<6.5% versus ≥6.5%All-cause mortality, myocardial failure, stroke, dialysis, serious infection4/3/2
Halkos et al. [22]2008USAProspective cohort308972.6In-hospital stay100%≤7% versus >7%All-cause mortality, MI, renal failure, atrial fibrillation, cerebrovascular accident4/2/1
Halkos et al. [23]2008USAProspective cohort320171.62.8 ± 1.4 yearsNA≤7% versus >7%Cerebrovascular disease, renal insufficiency, CHF, MI, peripheral vascular disease3/2/1
Knapik et al. [24]2011PolandProspective cohort73566.3In-hospital stay100%≤7% versus >7%All-cause mortality, stroke, renal failure, wound infection, perioperative MI4/3/2
Alserius et al. [25]2008SwedenProspective cohort12254.93.5 years100%≤7% versus >7%All-cause mortality, superficial sternal wound infections, mediastinitis4/1/2
Santos et al. [26]2015ArgentinaProspective cohort9682.3In-hospital stayNA≤7% versus >7%All-cause mortality, CHF, MI, renal failure, stroke4/2/2
Faritous et al. [27]2014IranProspective cohort21663.9In-hospital stayNA≤7% versus >7%All-cause mortality, arrhythmia, AMI, CHF4/1/2
Tsuruta et al. [28]2011JapanProspective cohort30679.13.6 ± 1.7 years100%<6.5% versus ≥6.5%MI, arrhythmia, congestive heart failure, sudden death4/3/2

CHF: congestive heart failure; MI: myocardial infarction; NA: not available.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.